FDA Approved: XELJANZ — Original Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

This FDA entry documents the original approval of XELJANZ (tofacitinib) by Pfizer for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• XELJANZ (tofacitinib)

Snippet

ORIG AP for XELJANZ (TOFACITINIB)